In vivo administration of Fms-like tyrosine kinase-3 ligand effectively stimulates lung dendritic cell expansion in mice

Chinese Medical Journal

Volumn 125, Issue 14, 2012, Pages 2562-2567

  Wang, Hong Wei ^a   Lu, Jiang Yang ^a   Wang, Lin ^a   Tian, Guang ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

CD205; Dendritic cell; Fms like tyrosine kinase 3 ligand; Lung; MHC II

Indexed keywords

CD11B ANTIGEN; CD135 ANTIGEN; CD45 ANTIGEN; GLYCOPROTEIN P 15095; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DENSITY; CELL EXPANSION; CONTROLLED STUDY; DENDRITIC CELL; DENSITY GRADIENT CENTRIFUGATION; FLOW CYTOMETRY; HISTOLOGY; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS CELL; MALE; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; ANTIGENS, CD; CELLS, CULTURED; DENDRITIC CELLS; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; LECTINS, C-TYPE; LUNG; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON, TRANSMISSION; RANDOM ALLOCATION; RECEPTORS, CELL SURFACE;

EID: 84864265156     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2012.14.030     Document Type: Article

References (24)

1. Joffre O, Nolte MA, Spörri R, Reis e Sousa C. Inflammatory signals in dendritic cell activation and the induction of adaptive immunity. Immunol Rev 2009; 227: 234-247.
2. Demedts IK, Bracke KR, Maes T, Joos GF, Brusselle GG. Different roles for human lung dendritic cell subsets in pulmonary immune defense mechanisms. Am J Respir Cell Mol Biol 2006; 35: 387-393.
3. Cook DN, Bottomly K. Innate immune control of pulmonary dendritic cell trafficking. Proc Am Thorac Soc 2007; 4: 234-239.
4. Ueno H, Klechevsky E, Morita R, Aspord C, Cao T, Matsui T, et al. Dendritic cell subsets in health and disease. Immunol Rev 2007; 219: 118-142.
5. Onai N, Obata-Onai A, Tussiwand R, Lanzavecchia A, Manz MG. Activation of the Flt3 signal transduction cascade rescues and enhances type I interferon-producing and dendritic cell development. J Exp Med 2006; 203: 227-238.
6. Kreiter S, Diken M, Selmi A, Diekmann J, Attig S, Hüsemann Y, et al. FLT3 ligand enhances the cancer therapeutic potency of naked RNA vaccines. Cancer Res 2011; 71: 6132-6142.
7. Bohannon J, Cui WH, Cox R, Przkora R, Sherwood E, Toliver-Kinsky T. Prophylactic treatment with Fms-like tyrosine kinase-3 ligand after burn Injury enhances global immune responses to infection. J Immunol 2008; 180: 3038-3048.
8. +dendritic cells. Chin Med J 2009; 122: 344-348.
9. Kingston D, Schmid MA, Onai N, Obata-Onai A, Baumjohann D, Manz MG. The concerted action of GM-CSF and Flt3-ligand on in vivo dendritic cell homeostasis. Blood 2009; 114: 835-843.
10. Woolard MD, Hodge LM, Jones HP, Schoeb TR, Simecka JW. The upper and lower respiratory tracts differ in their requirement of IFN-γ and IL-4 in controlling respiratory mycoplasma infection and disease. J Immunol 2004; 172: 6875-6883.
11. Masten BJ, Olson GK, Kusewitt DF, Lipscomb MF. Flt3 ligand preferentially increases the number of functionally active myeloid dendritic cells in the lungs of mice. J Immunol 2004; 172: 4077-4083.
12. Xu ZX, Xu Y, Zhu JK, Shi Q, Li Y, Zhang XG. Recombinant human Flt3 ligand exerts both direct and indirect effects on hematopoiesis. Chin Med J 2002; 115: 202-205.
13. -, and plasmacytoid dendritic cell generation in vitro using Flt3 ligand. Methods Mol Biol 2010; 595: 167-176.
14. Coates PT, Barratt-Boyes SM, Zhang L, Donnenberg VS, O'Connell PJ, Logar AJ, et al. Dendritic cell subsets in blood and lymphoid tissue of rhesus monkeys and their mobilization with Flt3 ligand. Blood 2003; 102: 2513-2521.
15. Maraskovsky E, Daro E, Roux E, Teepe M, Maliszewski CR, Hoek J, et al. In vivo generation of human dendritic cell subsets by Flt3 ligand. Blood 2000; 96: 878-884.
16. Teleshova N, Jones J, Kenney J, Purcell J, Bohm R, Gettie A, et al. Short-term Flt3L treatment effectively mobilizes functional macaque dendritic cells. J Leukoc Biol 2004; 75: 1102-1110.
17. Jefford M, Schnurr M, Toy T, Masterman KA, Shin A, Beecroft T, et al. Functional comparison of DCs generated in vivo with Flt3 ligand or in vitro from blood monocytes: differential regulation of function by specific classes of physiologic stimuli. Blood 2003; 102: 1753-1763.
18. Liu YJ. Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell 2001; 106: 259-262.
19. Smyth LA, Harker N, Turnbull W, El-Doueik H, Klavinskis L, Kioussis D, et al. The relative efficiency of acquisition of MHC: peptide complexes and cross-presentation depends on dendritic cell type. J Immunol 2008; 181: 3212-3220.
20. Butler M, Morel AS, Jordan WJ, Eren E, Hue S, Shrimpton RE, et al. Altered expression and endocytic function of CD205 in human dendritic cells, and detection of a CD205-DC-L-1 fusion protein upon dendritic cell maturation. Immunology 2007; 120: 362-371.
21. Wysocka M, Montaner LJ, Karp CL. Flt3 ligand treatment reverses endotoxin tolerance-related immunoparalysis. J Immunol 2005; 174: 7398-7402.
22. Pabst R, Lührmann A, Steinmetz I, Tschernig T. A single intratracheal dose of the growth factor Fms-like tyrosine kinase receptor-3 ligand induces a rapid differential increase of dendritic cells and lymphocyte subsets in lung tissue and bronchoalveolar lavage, resulting in an increased local antibody production. J Immunol 2003; 171: 325-330.
23. Dong J, McPherson CM, Stambrook PJ. Flt-3 ligand: a potent dendritic cell stimulator and novel antitumor agent. Cancer Biol Ther 2002; 1: 486-489.
24. Vollstedt S, Franchini M, Hefti HP, Odermatt B, O'Keeffe M, Alber G, et al. Flt3 ligand treated neonatal mice have increased innate immunity against intracellular pathogens and efficiently control virus infections. J Exp Med 2003; 197: 575-584.